Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Organogenesis Holdings Inc. ORGO NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
82/100
5/7 Pass
SharesGrow Intrinsic Value
$2.83
+8.8%
Analyst Price Target
$9.00
+246.2%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Organogenesis Holdings Inc. (ORGO), dont 23 achats et 26 ventes. Le total des achats d'initiés s'élève à $6.54M et le total des ventes d'initiés à $4.01M.

Les initiés notables ayant une activité récente comprennent Leibowitz Arthur S, Driscoll Michael Joseph, Cavorsi Robert. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — ORGO

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-03-09 Leibowitz Arthur S Director Achat Informatif 5,000 $2.68 $13.41K 291,014
2026-03-09 Driscoll Michael Joseph Director Achat Informatif 10,000 $2.67 $26.69K 225,707
2026-03-01 Cavorsi Robert Vice President, Strategy Retenue Fiscale RSU 700 $3.21 $2.25K 275,524
2026-02-18 Freedman Lori Chief Admin. and Legal Officer Attribution de RSU 115,812 $3.84 $444.72K 115,812
2026-02-18 Leibowitz Arthur S Director Attribution de RSU 48,828 - - 286,014
2026-02-18 Giacomin Jon L Director Attribution de RSU 48,828 - - 241,026
2026-02-18 Gillheeney Gary S. President and CEO Attribution de RSU 507,795 $3.84 $1.95M 507,795
2026-02-18 Grow Brian Chief Commercial Officer Attribution de RSU 133,630 $3.84 $513.14K 133,630
2026-02-18 Bilbo Patrick Chief Operating Officer Attribution de RSU 120,267 $3.84 $461.83K 120,267
2026-02-18 Montecalvo Antonio S. Vice President, Health Policy Attribution de RSU 23,162 $3.84 $88.94K 23,162
2026-02-18 Korfin Michele Ilene Director Attribution de RSU 48,828 - - 239,073
2026-02-18 Duraibabu Prathyusha Director Attribution de RSU 48,828 - - 247,047
2026-02-18 Francisco David Chief Financial Officer Attribution de RSU 111,358 $3.84 $427.61K 111,358
2026-02-18 Driscoll Michael Joseph Director Attribution de RSU 48,828 - - 215,707
2026-02-18 Quintero Gilberto Director Attribution de RSU 48,828 - - 239,073
2026-02-18 Cavorsi Robert Vice President, Strategy Attribution de RSU 53,452 $3.84 $205.26K 53,452
2026-02-18 Lustig Garrett Director Attribution de RSU 48,828 - - 125,742
2026-02-18 Mcguire Patrick Chief Accounting Officer Inconnu - - - 9,521
2026-02-18 Freedman Lori Chief Admin. and Legal Officer Retenue Fiscale RSU 14,411 $3.84 $55.34K 1,023,643
2026-02-18 Gillheeney Gary S. President and CEO Retenue Fiscale RSU 91,311 $3.84 $350.63K 4,232,087
2026-02-18 Grow Brian Chief Commercial Officer Retenue Fiscale RSU 11,887 $3.84 $45.65K 899,724
2026-02-18 Bilbo Patrick Chief Operating Officer Retenue Fiscale RSU 16,375 $3.84 $62.88K 1,128,312
2026-02-18 Montecalvo Antonio S. Vice President, Health Policy Retenue Fiscale RSU 3,778 $3.84 $14.51K 226,238
2026-02-18 Francisco David Chief Financial Officer Retenue Fiscale RSU 14,687 $3.84 $56.4K 731,312
2026-02-18 Cavorsi Robert Vice President, Strategy Retenue Fiscale RSU 5,487 $3.84 $21.07K 276,224
2026-02-15 Freedman Lori Chief Admin. and Legal Officer Retenue Fiscale RSU 13,510 $3.73 $50.39K 791,717
2026-02-15 Gillheeney Gary S. President and CEO Retenue Fiscale RSU 85,605 $3.73 $319.31K 3,243,917
2026-02-15 Grow Brian Chief Commercial Officer Retenue Fiscale RSU 11,144 $3.73 $41.57K 628,418
2026-02-15 Bilbo Patrick Chief Operating Officer Retenue Fiscale RSU 15,352 $3.73 $57.26K 884,648
2026-02-15 Montecalvo Antonio S. Vice President, Health Policy Retenue Fiscale RSU 3,523 $3.73 $13.14K 178,061
2026-02-15 Francisco David Chief Financial Officer Retenue Fiscale RSU 13,769 $3.73 $51.36K 506,647
2026-02-15 Cavorsi Robert Vice President, Strategy Retenue Fiscale RSU 5,442 $3.73 $20.3K 171,507
2025-12-16 Nussdorf Glenn H Director Vente Informative 200,000 $5.14 $1.03M 2,565,591
2025-11-26 Nussdorf Glenn H 10 Percent Owner Vente Informative 187,957 $5.29 $994.29K 2,765,591
2025-11-25 Nussdorf Glenn H 10 Percent Owner Vente Informative 12,043 $5.30 $63.83K 2,953,548
2025-11-24 Nussdorf Glenn H 10 Percent Owner Vente Informative 100,000 $5.34 $534K 2,965,591
2025-08-11 Grow Brian Chief Commercial Officer Exercice d'Options (Vente) 4,060 $2.47 $10.03K -
2025-07-16 Cavorsi Robert Vice President, Strategy Retenue Fiscale RSU 360 $4.47 $1.61K 189,165
2025-06-10 Nussdorf Glenn H 10 Percent Owner Vente Informative 18,620 $3.56 $66.26K 335,719
2025-06-09 Nussdorf Glenn H 10 Percent Owner Vente Informative 4,156 $3.50 $14.55K 354,339
2025-06-06 Freedman Lori Chief Admin. and Legal Officer Achat Informatif 9,022 $2.99 $26.95K 846,459
2025-06-05 Freedman Lori Chief Admin. and Legal Officer Achat Informatif 142,379 $2.91 $413.63K 837,437
2025-06-04 Freedman Lori Chief Admin. and Legal Officer Achat Informatif 100,863 $2.82 $284.72K 695,058
2025-05-15 Nussdorf Glenn H 10 Percent Owner Achat Informatif 107,494 $2.99 $321K 358,495
2025-05-14 Nussdorf Glenn H 10 Percent Owner Achat Informatif 251,001 $3.09 $775.04K 251,001
2025-03-09 Cavorsi Robert Vice President, Strategy Retenue Fiscale RSU 61 $5.16 $314.76 189,525
2025-03-04 Driscoll Michael Joseph Director Vente Informative 25,000 $5.10 $127.54K 166,879
2025-03-01 Cavorsi Robert Vice President, Strategy Retenue Fiscale RSU 667 $6.21 $4.14K 189,796
2025-02-19 Freedman Lori Chief Admin. and Legal Officer Attribution de RSU 167,625 $3.53 $591.72K 167,625
2025-02-19 Leibowitz Arthur S Director Attribution de RSU 49,575 - - 237,186
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message